SKI Market

Indian Indices

Sensex

84,273.92 208.17
( 0.25%)

Global Indices

Nasdaq

50,149.26 12.58
(0.03%)

Dow Jones

6,984.17 30.87
(0.44%)

Hang Seng

57,678.97 1,315.03
(2.33%)

Nikkei 225

10,354.92 -31.31
(-0.30%)

Forex

USD-INR

90.44 0.11
(0.13%)

EUR-INR

106.84 0.33
(0.31%)

GBP-INR

123.03 0.35
(0.29%)

JPY-INR

0.58 0.00
(-0.07%)

YOU ARE HERE :
HOME
Markets
Equity
Company News

EQUITY - MARKET SCREENER

Lupin Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500257

INE326A01037

595.7690006

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LUPIN

18.83

100484.97

EPS(TTM)

Face Value()

Div & Yield %

116.75

0.55

Date	Headline
10-Feb-2026	Lupin settles patent dispute with Astellas
02-Feb-2026	Lupin announces strategic collaboration with TB Alliance
02-Feb-2026	Lupin launches Dasatinib Tablets in U.S. market
02-Feb-2026	Lupin joins hands with TB Alliance to accelerate clinical development of Telacebec
29-Jan-2026	Lupin to discuss results
27-Jan-2026	Lupin allots 1.69 lakh equity shares under ESOP
23-Jan-2026	Lupin receives S&P Global ESG score of 91 in 2025
21-Jan-2026	Lupin signs licensing and supply agreement with Galenicum Health
30-Dec-2025	Lupin enters licensing agreement with Gan & Lee Pharmaceuticals
30-Dec-2025	Lupin signs exclusive licensing deal with Gan & Lee for novel GLP-1 receptor agonist

<< < 1 2 3 ... > >>

84,273.92 208.17 ( 0.25%)

50,149.26 12.58 (0.03%)

6,984.17 30.87 (0.44%)

57,678.97 1,315.03 (2.33%)

10,354.92 -31.31 (-0.30%)

90.44 0.11 (0.13%)

106.84 0.33 (0.31%)

123.03 0.35 (0.29%)

0.58 0.00 (-0.07%)